Carnitine palmitoyltransferase-1b (CPT1b) deficiency aggravates pressure-overload-induced cardiac hypertrophy due to lipotoxicity
This distinguishes it from GLP-1 medications, which in some patients have been associated with significant lean mass reduction alongside fat loss
Your liver is a marvel, make no mistake
With promising clinical results, these therapies bring Read More GLP1s for Adolescents With Type 2 Diabetes and Obesity: A New Era, New Responsibilities As GLP1 therapies expand into pediatric care, a growing number of providers are asking how to best implement them in adolescents diagnosed with both type 2 diabetes and obesity
Sleep and Stress Statistics. NAPLAB , www.naplab.com/guides/sleep-stress-statistics/.
Purpose-built for physicians GLP-1 receptor agonists linked to lower mortality, respiratory failure in PAH Key takeaways: A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory failure, atrial fibrillation and ED visits